. Author manuscript; available in PMC: 2019 May 1.

Published in final edited form as: Am Heart J. 2017 Dec 13;199:181–191. doi: 10.1016/j.ahj.2017.11.016

Table 3.

Univariable Logistic Regression for In-hospital Adverse Event

Variable	OR [95% CI]	P-value
History of CAD^*	2.56 [0.87, 7.52]	0.087
Prior MI^*	4.44 [1.45, 13.58]	0.009
Prior CABG^*	8.33 [1.9, 36.49]	0.005
Prior PCI^*	2.25 [0.67, 7.53]	0.189
Ischemic Cardiomyopathy	6.19 [1.98, 19.34]	0.002
Aspirin^*	2.20 [0.79, 6.15]	0.133
Hydralazine-ISDN	3.84 [1.02, 14.39]	0.046
Mineralocorticoid Receptor Antagonist	0.03 [0.01, 1.01]	0.053
ACEI/ARB^*	0.43 [0.16, 1.15]	0.094
RV systolic dysfunction (≥ moderate)	2.47 [0.88, 6.99]	0.087
Heart rate (min⁻¹)^†	1.03 [1.00, 1.05]	0.048
Cardiac Output (L/min)^†	0.51 [0.30, 0.86]	0.012
SVR (dyn·s·cm⁻⁵)	1.00 [1.00, 1.001]	0.044
PVR (Wood Units)	1.24 [0.99, 1.54]	0.055
Stroke volume index (ml/m²/beat)^†	0.86 [0.78, 0.96]	0.005
LVSWI (g/m²/beat)^†	0.87 [0.76, 0.98]	0.024
RVSWI (g/m²/beat)^†	0.81 [0.66, 0.99]	0.036
RVCPI (per 0.10 W/m²)^†	0.23 [0.07, 0.70]	0.010
LVCPI (per 0.10 W/m²)	0.44 [0.23, 0.84]	0.013

Candidate variables from univariable logistic regression (P<0.2). CAD, coronary artery disease; MI, myocardial infarction; CABG, coronary artery bypass graft; PCI, percutaneous coronary intervention; ISDN, isosorbide dinitrate; ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; RV, right ventricular; SVR, systemic vascular resistance; PVR, pulmonary vascular resistance; LVSWI, LV stroke work index; RVSWI, RV stroke work index; RVCPI, RV cardiac power index; LVCPI, LV cardiac power index; OR, Odds ratio; W, Watts.

collinear with ischemic cardiomyopathy,

^†

collinear with LVCPI.